News
AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a ...
The pharmaceutical giant sees the drug, gefurulimab, as a more convenient, self-administered alternative to the infused ...
WRIC Richmond on MSN5h
Youngkin discusses AstraZeneca facility coming to Virginia
Governor Glenn Youngkin spoke with 8News about AstraZeneca’s recent announcement to build their world’s-largest manufacturing ...
The biopharmaceutical company said the investment includes plans for a new manufacturing center focused on chronic diseases.
InsideNoVa on MSN2d
AstraZeneca to build its largest-ever manufacturing facility in Virginia, creating hundreds of jobs
In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...
Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...
President Donald Trump referenced the announcement the following day in Oval Office remarks, framing AstraZeneca’s overall ...
UK-based pharmaceutical giant AstraZeneca plans to build its largest drug manufacturing facility in Virginia, creating ...
AstraZeneca (AZN) stock is in focus as the company's experimental drug gefurulimab for generalized myasthenia gravis hits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback